MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, proposed an innovative hardware acceleration technology that converts the quantum tensor network ...

In-depth review of Arcanum Pulse, a non-custodial crypto trading bot on Telegram for Bybit. Features risk mitigation & a success-based fee model.

Meta is turning its AI ambitions into a concrete, industrial-scale buildout. With Meta CEO Mark Zuckerberg now formally ...

Researchers utilize superpixels to enhance the robustness and accuracy of vision-based structural health monitoring JEOLLANAM-DO PROVINCE, South Korea, Jan. 12, 2026 /PRNewswire/ -- Structural health ...

Structural health monitoring (SHM) and condition monitoring are crucial processes that ensure reliability and safety of ...

AI, machine learning, and algorithm-driven analytics are changing the face of foreign exchange (FX) trading and investment.

MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, launched a brand-new scalable quantum Fourier transform simulator technology based on multi-FPGA and ...

The U.S. Senate Banking Committee will not have any markup hearings on market structure legislation defining how federal regulators can oversee the industry until next year, punting on a hoped-for ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

A2Z/ ├── Problems/ # Solved problems organized by difficulty │ ├── Easy/ # Easy level problems │ ├── Medium/ # Medium level problems │ └── Hard/ # Hard level problems │ ├── DataStructures/ # Core data ...

One day in November, a product strategist we’ll call Michelle (not her real name), logged into her LinkedIn account and switched her gender to male. She also changed her name to Michael, she told ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...